Back
Vertex Pharmaceuticals Vs. Gilead Sciences Industry Stock Comparison
Buy
58
VRTX
Vertex Pharmaceuticals
Last Price:
484.17
Seasonality Move:
7.3%
Buy
56
GILD
Gilead Sciences
Last Price:
92.11
Seasonality Move:
9.71%
Buy
58
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $494.61. The Score for VRTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $92.63. The Score for GILD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $494.61
The current trend is moderately bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $92.63
The current trend is moderately bullish and GILD is experiencing slight buying pressure.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 55.07 | Buy |
| Chaikin Money Flow: | -8002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 59.21 | Buy |
| Chaikin Money Flow: | -2406298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 496.53 | Sell |
| 20-day SMA: | 484.21 | Buy |
| 50-day SMA: | 475.74 | Buy |
| 200-day SMA: | 452.89 | Buy |
| 8-day EMA: | 494.36 | Buy |
| 20-day EMA: | 486.68 | Buy |
| 50-day EMA: | 479.89 | Buy |
| 200-day EMA: | 452.16 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.78 | Sell |
| 20-day SMA: | 90.33 | Buy |
| 50-day SMA: | 86.06 | Buy |
| 200-day SMA: | 74.68 | Buy |
| 8-day EMA: | 93.51 | Sell |
| 20-day EMA: | 90.9 | Buy |
| 50-day EMA: | 86.41 | Buy |
| 200-day EMA: | 78.3 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.55 per share, and an increase next year of $18.35 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.43 per share, and an increase next year of $3.14 per share.
Vertex Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||